Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir

PURPOSE: People chronically infected with hepatitis C virus (HCV) have diminished patient-reported outcomes (PROs). This study aimed to compare the impact of elbasvir/grazoprevir (EBR/GZR) treatment versus sofosbuvir with pegylated interferon and ribavirin (SOF/PR) on changes in PROs: 1) during the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Patient Prefer Adherence
Autors principals: Ng, Xinyi, Nwankwo, Chizoba, Arduino, Jean Marie, Corman, Shelby, Lasch, Kathryn Eilene, Lustrino, Jacqueline Mary, Patel, Sushma, Platt, Heather Loryn, Qiu, Jingjun, Sperl, Jan
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6294167/
https://ncbi.nlm.nih.gov/pubmed/30587935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S172732
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars